These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21029156)

  • 1. Update on the use of melatonin in pediatrics.
    Gitto E; Aversa S; Reiter RJ; Barberi I; Pellegrino S
    J Pineal Res; 2011 Jan; 50(1):21-8. PubMed ID: 21029156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system.
    Reiter RJ; Acuña-Castroviejo D; Tan DX; Burkhardt S
    Ann N Y Acad Sci; 2001 Jun; 939():200-15. PubMed ID: 11462772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence.
    Reiter RJ; Tan DX; Manchester LC; Qi W
    Cell Biochem Biophys; 2001; 34(2):237-56. PubMed ID: 11898866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin.
    Gitto E; Pellegrino S; Gitto P; Barberi I; Reiter RJ
    J Pineal Res; 2009 Mar; 46(2):128-39. PubMed ID: 19054296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin in relation to cellular antioxidative defense mechanisms.
    Reiter RJ; Carneiro RC; Oh CS
    Horm Metab Res; 1997 Aug; 29(8):363-72. PubMed ID: 9288572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biogenic amines in the reduction of oxidative stress: melatonin and its metabolites.
    Reiter RJ; Tan DX; Jou MJ; Korkmaz A; Manchester LC; Paredes SD
    Neuro Endocrinol Lett; 2008 Aug; 29(4):391-8. PubMed ID: 18766165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin: reducing molecular pathology and dysfunction due to free radicals and associated reactants.
    Reiter RJ; Tan DX; Allegra M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():3-8. PubMed ID: 12019343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin as pharmacologic support in burn patients: a proposed solution to thermal injury-related lymphocytopenia and oxidative damage.
    Maldonado MD; Murillo-Cabezas F; Calvo JR; Lardone PJ; Tan DX; Guerrero JM; Reiter RJ
    Crit Care Med; 2007 Apr; 35(4):1177-85. PubMed ID: 17312564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation.
    Reiter RJ
    Front Neuroendocrinol; 1995 Oct; 16(4):383-415. PubMed ID: 8557171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage.
    Reiter RJ; Tan DX; Gitto E; Sainz RM; Mayo JC; Leon J; Manchester LC; Vijayalaxmi ; Kilic E; Kilic U
    Pol J Pharmacol; 2004; 56(2):159-70. PubMed ID: 15156066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin: action as antioxidant and potential applications in human disease and aging.
    Bonnefont-Rousselot D; Collin F
    Toxicology; 2010 Nov; 278(1):55-67. PubMed ID: 20417677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of oxygen toxicity by melatonin.
    Reiter RJ; Tan DX; Qi WB
    Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):575-81. PubMed ID: 10437151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin defeats neurally-derived free radicals and reduces the associated neuromorphological and neurobehavioral damage.
    Reiter RJ; Tan DX; Manchester LC; Tamura H
    J Physiol Pharmacol; 2007 Dec; 58 Suppl 6():5-22. PubMed ID: 18212398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin as a radioprotective agent: a review.
    Vijayalaxmi ; Reiter RJ; Tan DX; Herman TS; Thomas CR
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):639-53. PubMed ID: 15183467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin: Nature's most versatile biological signal?
    Pandi-Perumal SR; Srinivasan V; Maestroni GJ; Cardinali DP; Poeggeler B; Hardeland R
    FEBS J; 2006 Jul; 273(13):2813-38. PubMed ID: 16817850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Melatonin and oxidative stress in elderly patients with type 2 diabetes].
    Kupczyk D; Rybka J; Kedziora-Kornatowska K; Kedziora J
    Pol Merkur Lekarski; 2010 May; 28(167):407-9. PubMed ID: 20568408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of melatonin in experimental free radical-related ocular diseases.
    Siu AW; Maldonado M; Sanchez-Hidalgo M; Tan DX; Reiter RJ
    J Pineal Res; 2006 Mar; 40(2):101-9. PubMed ID: 16441546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions.
    Zhang HM; Zhang Y
    J Pineal Res; 2014 Sep; 57(2):131-46. PubMed ID: 25060102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence.
    Escames G; Acuña-Castroviejo D; López LC; Tan DX; Maldonado MD; Sánchez-Hidalgo M; León J; Reiter RJ
    J Pharm Pharmacol; 2006 Sep; 58(9):1153-65. PubMed ID: 16945173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin inhibits free radical-mediated mitochondrial-dependent hepatocyte apoptosis and liver damage induced during malarial infection.
    Guha M; Maity P; Choubey V; Mitra K; Reiter RJ; Bandyopadhyay U
    J Pineal Res; 2007 Nov; 43(4):372-81. PubMed ID: 17910606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.